Menopause Hormone Therapy (HRT) in Peabody, MA

Bioidentical hormones in Peabody: what it means

"Bioidentical" is a word compounding pharmacies often use in marketing, but what it describes is real: a hormone built like the body's own. Estradiol, the main estrogen the ovaries make before menopause, and micronized progesterone both fit that description. FDA-approved versions of both are sold by prescription at retail pharmacies.

Peabody has fewer OB-GYNs per resident than the country: the federal NPI registry lists 4 with a primary practice address in the city, 7.4 per 100,000 residents against 17.8 nationally and below Massachusetts's 21.9. Set against the city's 7,477 women aged 45 to 64, that is one OB-GYN for roughly every 1,870.

Within 25 miles of Peabody there are 979 OB-GYNs for 3,374,331 residents (29.0 per 100,000), well above the national rate; 100 are in the city or within 10 miles. Whether or not you have an OB-GYN, you can ask a physician licensed in Massachusetts about menopause hormone therapy online from Peabody, with no waiting room.

"BHRT" often means compounded hormones, a cream, a blend such as Bi-Est or a pellet that a pharmacy mixes for one prescription. Compounded drugs are not FDA-approved, so the FDA cannot assure their safety, effectiveness or dose. The FDA says it has no evidence that compounded "bioidentical hormones" are safe and effective, or more effective than FDA-approved hormone therapy. When the National Academies reviewed them in 2020, the evidence was mostly low quality, such as anecdotes and patient reports.

Through VevaMD, a physician licensed in Massachusetts decides whether hormone therapy fits you and, if so, the form: an estradiol pill, patch, cream or vaginal cream, with progesterone if you have a uterus. There are no pellets. Because the dispensing pharmacy also compounds, you can ask whether your estradiol or progesterone is an FDA-approved product. Testosterone cream for women and Bi-Est are compounded and not FDA-approved.

A pellet clinic is a different model: it implants a hormone pellet under the skin during a visit, and compounded pellets are not FDA-approved. The Endocrine Society cites blood levels well above the expected range in women using compounded pellets. ACOG's guidance is to prefer FDA-approved menopause hormone therapy to compounded hormones.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11